These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14096418)

  • 1. STUDIES OF THE MODE OF ACTION OF TUMOUR-GROWTH-INHIBITING ALKYLATING AGENTS. IV. IN-VITRO REACTIONS OF 2-CHLOROETHYLARYLAMINES.
    ROBERTS JJ; WARWICK GP
    Biochem Pharmacol; 1963 Dec; 12():1315-9. PubMed ID: 14096418
    [No Abstract]   [Full Text] [Related]  

  • 2. STUDIES OF THE MODE OF ACTION OF TUMOUR-GROWTH-INHIBITING ALKYLATING AGENTS. V. THE METABOLISM OF 2-CHLOROETHYLARYLAMINES.
    ROBERTS JJ; WARWICK GP
    Biochem Pharmacol; 1963 Dec; 12():1321-8. PubMed ID: 14096419
    [No Abstract]   [Full Text] [Related]  

  • 3. ALKYLATING AGENTS DERIVED FROM INDOLES. IV. SYNTHESIS OF THE 5-NITROGEN MUSTARD OF INDOLE-3-CARBOXYLIC ACID.
    DEGRAW J; GOODMAN L
    J Med Chem; 1964 Mar; 7():213-5. PubMed ID: 14187378
    [No Abstract]   [Full Text] [Related]  

  • 4. A STUDY OF COMPARATIVE CHEMICAL AND BIOLOGICAL ACTIVITIES OF ALKYLATING AGENTS.
    BARDOS TJ; DATTA-GUPTA N; HEBBORN P; TRIGGLE DJ
    J Med Chem; 1965 Mar; 8():167-74. PubMed ID: 14335145
    [No Abstract]   [Full Text] [Related]  

  • 5. COLORIMETRIC METHOD FOR DETERMINATION OF URACIL MUSTARD AND RELATED ALKYLATING AGENTS.
    PETERING HG; VANGIESSEN GJ
    J Pharm Sci; 1963 Dec; 52():1159-62. PubMed ID: 14088966
    [No Abstract]   [Full Text] [Related]  

  • 6. POTENTIAL ANTICANCER AGENTS. LXXX. ALKYLATING AGENTS RELATED TO PHENYLALANINE MUSTARD. VI. ENANTIOMERIC META-PHENYLALANINE MUSTARDS.
    GRAM HF; BERRIDGE BJ; ACTON EM; GOODMAN L
    J Med Chem; 1963 Jan; 6():85-7. PubMed ID: 14174040
    [No Abstract]   [Full Text] [Related]  

  • 7. REDUCTION OF THE TOXICITY OF "RADIOMIMETIC" ALKYLATING AGENTS IN RATS BY THIOL PRE-TREATMENT. IV. PROTECTION AGAINST BONE MARROW DAMAGE.
    CONNORS TA; DOUBLE JA; ELSON LA; JENEY A
    Biochem Pharmacol; 1965 Apr; 14():569-77. PubMed ID: 14330623
    [No Abstract]   [Full Text] [Related]  

  • 8. REDUCTION OF THE TOXICITY OF 'RADIOMIMETIC' ALKYLATING AGENTS IN RATS BY THIOL PRETREATMENT. 3. THE MECHANISM OF THE PROTECTIVE ACTION OF THIOSULPHATE.
    CONNORS TA; JENEY A; JONES M
    Biochem Pharmacol; 1964 Dec; 13():1545-50. PubMed ID: 14248383
    [No Abstract]   [Full Text] [Related]  

  • 9. REDUCTION OF THE TOXICITY OF "RADIOMIMETIC" ALKYLATING AGENTS IN RATS BY THIOL PRETREATMENT. II. MECHANISM OF PROTECTION.
    CALCUTT G; CONNORS TA; ELSON LA; ROSS WC
    Biochem Pharmacol; 1963 Aug; 12():833-7. PubMed ID: 14071540
    [No Abstract]   [Full Text] [Related]  

  • 10. EXPERIMENTAL CHEMOTHERAPY STUDIES. IV. THE PROTECTIVE ACTION OF MERCAPTOALKYLAMINES AGAINST ALKYLATING AGENTS.
    RUTMAN RJ; LEWIS FS; PRICE CC
    Cancer Res; 1964 May; 24():626-33. PubMed ID: 14188465
    [No Abstract]   [Full Text] [Related]  

  • 11. EVIDENCE FOR THE ACTION OF ALKYLATING AGENTS ON DEOXYRIBONUCLEIC ACID.
    BROOKES P; LAWLEY PD
    Exp Cell Res; 1963; 24():SUPPL9:521-4. PubMed ID: 14046251
    [No Abstract]   [Full Text] [Related]  

  • 12. [TUMOUR CHEMOTHERAPY. XII. SYNTHESIS OF NITROGEN MUSTARD RELATED TO ANTIARTHRITICS].
    DENG RS
    Yao Xue Xue Bao; 1962 Jan; 9():18-22. PubMed ID: 14074948
    [No Abstract]   [Full Text] [Related]  

  • 13. [Structure and mode of action of alkylating agents used in the therapy of neoplastic diseases].
    Borresen HC
    Nord Med; 1969 Jan; 81(3):65-72. PubMed ID: 5767356
    [No Abstract]   [Full Text] [Related]  

  • 14. POTENTIAL ANTICANCER AGENTS. IV. HETEROCYCLIC PHOSPHORAMIDE NITROGEN MUSTARDS.
    ZIMMER H; SILL AD
    Arzneimittelforschung; 1964 Feb; 14():150-1. PubMed ID: 14229652
    [No Abstract]   [Full Text] [Related]  

  • 15. [CHANGES IN THE AMOUNT OF SULFHYDRYL COMPOUNDS IN THE BLOOD SERUM AND TISSUES OF TRANSPLANTED RAT TUMORS UNDER THE INFLUENCE OF ANTINEOPLASTIC ALKYLATING PREPARATIONS].
    KULIK GI
    Vopr Onkol; 1964; 10():70-4. PubMed ID: 14259823
    [No Abstract]   [Full Text] [Related]  

  • 16. [TUMOUR CHEMOTHERAPY. XIII. SOME SCHIFF'S BASES CONTAINING THE NITROGEN MUSTARD GROUPING].
    LI SW; KAO YS
    Yao Xue Xue Bao; 1962 Mar; 9():167-73. PubMed ID: 14073962
    [No Abstract]   [Full Text] [Related]  

  • 17. EFFECT OF HEPARIN-BOUND ALKYLATING AGENTS AND ENZYME INHIBITORS ON NEOPLASTIC GROWTH.
    CSABA G; KOROESI J; HORVATH C; MOLD K; ACS T
    Neoplasma; 1964; 11():137-44. PubMed ID: 14160693
    [No Abstract]   [Full Text] [Related]  

  • 18. THE EFFECT OF GLUCOSE PRETREATMENT ON THE CARCINOSTATIC AND TOXIC ACTIVITIES OF SOME ALKYLATING AGENTS.
    CONNORS TA; MITCHLEY BC; ROSENOER VM; ROSS WC
    Biochem Pharmacol; 1964 Mar; 13():395-400. PubMed ID: 14157601
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative investigation of the chemotherapeutic action of N-oxide-mustard gas and other alkylating compounds in rat tumors].
    DANNEBERG P; DRUCKREY H; KAISER K; LO HW; MECKE R; NIEPER HA; SCHMAHL D
    Arzneimittelforschung; 1956 Sep; 6(9):539-50. PubMed ID: 13373668
    [No Abstract]   [Full Text] [Related]  

  • 20. SYNTHESIS OF POTENTIAL ANTINEOPLASTIC AGENTS. X. PREPARATION AND REACTIONS OF ALDEHYDES RELATED TO BENZALDEHYDE MUSTARD.
    POPP FD
    J Med Chem; 1964 Mar; 7():210-2. PubMed ID: 14187377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.